Beyond Air, Inc. (XAIR): Price and Financial Metrics


Beyond Air, Inc. (XAIR): $6.50

-0.16 (-2.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

XAIR POWR Grades


  • XAIR scores best on the Growth dimension, with a Growth rank ahead of 41.63% of US stocks.
  • XAIR's strongest trending metric is Momentum; it's been moving down over the last 163 days.
  • XAIR ranks lowest in Stability; there it ranks in the 4th percentile.

XAIR Stock Summary

  • Beyond Air Inc's stock had its IPO on May 8, 2019, making it an older stock than just 6.84% of US equities in our set.
  • XAIR's price/sales ratio is 639.71; that's higher than the P/S ratio of 99.17% of US stocks.
  • Revenue growth over the past 12 months for Beyond Air Inc comes in at -57.69%, a number that bests just 3.03% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Beyond Air Inc are VBIV, CRMD, BLI, CLSN, and HRTX.
  • Visit XAIR's SEC page to see the company's official filings. To visit the company's web site, go to www.beyondair.net.

XAIR Valuation Summary

  • In comparison to the median Healthcare stock, XAIR's price/sales ratio is 10663.16% higher, now standing at 409.
  • Over the past 28 months, XAIR's price/sales ratio has gone NA NA.
  • Over the past 28 months, XAIR's price/earnings ratio has gone down 4.8.

Below are key valuation metrics over time for XAIR.

Stock Date P/S P/B P/E EV/EBIT
XAIR 2021-08-31 409.0 7.9 -11.5 -10.4
XAIR 2021-08-30 419.9 8.1 -11.8 -10.7
XAIR 2021-08-27 423.6 8.2 -11.9 -10.8
XAIR 2021-08-26 406.1 7.8 -11.4 -10.3
XAIR 2021-08-25 383.1 7.4 -10.8 -9.6
XAIR 2021-08-24 354.8 6.8 -10.0 -8.8

XAIR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • XAIR has a Quality Grade of D, ranking ahead of 10.23% of graded US stocks.
  • XAIR's asset turnover comes in at 0.019 -- ranking 165th of 186 Medical Equipment stocks.
  • ANGO, CLPT, and EW are the stocks whose asset turnover ratios are most correlated with XAIR.

The table below shows XAIR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.019 1 -4.212
2021-03-31 0.030 1 -5.011
2020-12-31 0.020 1 -7.880
2020-09-30 0.029 1 -5.011
2020-06-30 0.048 1 -4.730
2020-03-31 0.081 1 -3.709

XAIR Price Target

For more insight on analysts targets of XAIR, see our XAIR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.00 Average Broker Recommendation 1.3 (Strong Buy)

XAIR Stock Price Chart Interactive Chart >

Price chart for XAIR

XAIR Price/Volume Stats

Current price $6.50 52-week high $16.41
Prev. close $6.66 52-week low $4.62
Day low $6.39 Volume 46,324
Day high $6.72 Avg. volume 314,519
50-day MA $10.46 Dividend yield N/A
200-day MA $8.63 Market Cap 173.16M

Beyond Air, Inc. (XAIR) Company Bio


Beyond Air, Inc. operates as a medical device and biopharmaceutical company. The Company focuses on the discovery and development of a nitric oxide formulation and delivery systems to treat various respiratory diseases. Beyond Air serves patients and customers in the United States and Israel.


XAIR Latest News Stream


Event/Time News Detail
Loading, please wait...

XAIR Latest Social Stream


Loading social stream, please wait...

View Full XAIR Social Stream

Latest XAIR News From Around the Web

Below are the latest news stories about Beyond Air Inc that investors may wish to consider to help them evaluate XAIR as an investment opportunity.

Head-To-Head Contrast: TELA Bio (NASDAQ:TELA) vs. Beyond Air (NASDAQ:XAIR)

TELA Bio (NASDAQ:TELA) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability. Profitability This table compares TELA Bio and Beyond Airs net margins, return on equity and []

Transcript Daily | December 18, 2021

Beyond Air CEO buys $341K in common stock

No summary available.

Seeking Alpha | December 14, 2021

Beyond Air Inc (XAIR) CEO and Chairman of the Board Steven A. Lisi Bought $341,200 of Shares

CEO and Chairman of the Board of Beyond Air Inc (30-Year Financial, Insider Trades) Steven A. Lisi (insider trades) bought 40,000 shares of XAIR on 12/10/2021 at an average price of $8.53 a share.

Yahoo | December 14, 2021

Insider Buying: Beyond Air, Inc. (NASDAQ:XAIR) CEO Acquires 40,000 Shares of Stock

Beyond Air, Inc. (NASDAQ:XAIR) CEO Steven A. Lisi acquired 40,000 shares of the business’s stock in a transaction on Friday, December 10th. The stock was acquired at an average cost of $8.53 per share, with a total value of $341,200.00. The transaction was disclosed in a filing with the SEC, which can be accessed through […]

Dakota Financial News | December 13, 2021

Goldman Sachs Group Inc. Purchases 15,246 Shares of Beyond Air, Inc. (NASDAQ:XAIR)

Goldman Sachs Group Inc. raised its position in Beyond Air, Inc. (NASDAQ:XAIR) by 134.4% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 26,586 shares of the companys stock after acquiring an additional 15,246 shares during the quarter. Goldman Sachs Group Inc. owned approximately 0.11% []

Transcript Daily | December 12, 2021

Read More 'XAIR' Stories Here

XAIR Price Returns

1-mo N/A
3-mo -35.13%
6-mo -15.25%
1-year 3.83%
3-year 30.00%
5-year N/A
YTD -31.14%
2021 79.13%
2020 0.76%
2019 12.47%
2018 -6.81%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8259 seconds.